Home » Newsletters » BioWorld Science

BioWorld Science

May 12, 2011

View Archived Issues

Novel free fatty acid FFA1 receptor agonists for diabetes claimed by Lilly

Preclinical safety data on FCFD-4514-S enable advancement to clinic for geographic atrophy

Clinical trial tests effect of food, H2R blockade and vitamin C on GSK-1322322 pharmacokinetics

PEM antibiotic POL-7080 well tolerated in phase I study

KAG-308 has beneficial effects in models of chronic colitis

Preclinical data disclosed on RDX-5791 for constipation

New anticancer agents prepared by Chinese scientists

OPKO Health receives grant to support development of therapeutics for Dravet syndrome

Merck & Co. patents novel acyl-CoA desaturase inhibitors

Biodel's ultrarapidly acting insulin formulations enter pump trial in type 1 diabetes

FDA clears Meridian Bioscience's Premier C. difficile GDH immunoassay

Novel antibacterial agents presented

Tibotec designs novel HIV integrase inhibitors

Encore Therapeutics finalizes novel nanoemulsion progesterone formulation ETI-411

New calcitonin CGRP receptor antagonists disclosed

Duquesne University presents new tamoxifen-melatonin hybrid ligand

Nymox to begin recruitment in new clinical trial of NX-1207

Talon Therapeutics to begin recruitment in phase III Marqibo trial

Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation

Summit nominates SMT-19969 as preclinical development candidate against C. difficile infection

Verona Pharma begins new phase II trial of RPL-554 in asthma

EMA acknowledges that Clinuvel's proposed dossier for afamelanotide meets all filing requirements

Meda completes acquisition of atopic dermatitis treatment Elidel

Hervix has long-term benefit on recurrence of bladder cancer

CrystalGenomics completes phase I trial of CG-400549, an antibiotic against resistant bacteria

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...